NDC 54925-063-10 - Atropine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54925-063
- Requested NDC
- 54925-063-10
- Package NDCs from labels
- 54925-063-10
- Manufacturer
- Med-Pharmex, Inc
- Effective date
- 2008-04-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atropine Sulfate - Med-Pharmex, Inc | Med-Pharmex, Inc | 2008-04-01 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ATROPINE SULFATE | ACTIVE INGREDIENT | 03J5ZE7KA5 | ATROPINE SULFATE INJECTION, SOLUTION [MED-PHARMEX, INC] | 1 | |
| ATROPINE | ACTIVE MOIETY | 7C0697DR9I | ATROPINE SULFATE INJECTION, SOLUTION [MED-PHARMEX, INC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diphenoxylate hydrochloride and atropine sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Chartwell RX, LLC | 240b537e-ff9b-45e3-9398-584372bd707a | 2025-12-10 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine | ATROPINE SULFATE | Amneal Pharmaceuticals NY LLC | f8718be5-8fa4-4c36-a4fd-fac7c3953f5a | 2025-12-04 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| atropine sulfate | ATROPINE SULFATE | Amneal Pharmaceuticals LLC | 80a31286-a741-4440-b200-290c08925d06 | 2025-12-01 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | NorthStar RxLLC | f750135c-e6bf-4aa7-a343-87b1204df94f | 2025-11-12 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Motofen | DIFENOXIN AND ATROPINE SULFATE | Sebela Pharmaceuticals Inc. | 4cd3f029-a5e3-5812-e054-00144ff8d46c | 2025-11-08 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE MONOHYDRATE | Medical Purchasing Solutions, LLC | 423fc064-57cb-8308-e063-6394a90a2617 | 2025-10-28 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Lifestar Pharma LLC | b5f78b2a-56d1-4400-9d2f-b033cc13d26e | 2025-10-13 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Hikma Pharmaceuticals USA Inc. | a66eecf9-2d8b-4e2d-8a05-d718dcbc3542 | 2025-10-08 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| ATROPINE SULFATE | ATROPINE SULFATE | Accord Healthcare, Inc., | c82cb295-ffce-47d6-97ad-a8aa723f4e4f | 2025-10-06 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Medical Purchasing Solutions, LLC | 3fa81939-4495-28d5-e063-6394a90a1f2d | 2025-09-25 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | ProPharma Distribution | 3ef1a1a0-93c1-e6b6-e063-6294a90aa2b6 | 2025-09-17 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE INJECTION | ProPharma Distribution | 3eeed115-0e17-c4b2-e063-6294a90a29b7 | 2025-09-16 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | ProPharma Distribution | 3eef6300-9c78-82b2-e063-6294a90a5499 | 2025-09-16 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | American Health Packaging | d0a1c80d-6aae-4886-8c25-e2d29ca0836b | 2025-07-30 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Hikma Pharmaceuticals USA Inc. | 88ed4ccf-9e35-4142-a5eb-d2b5edd36956 | 2025-06-26 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine sulfate | ATROPINE SULFATE | Somerset Therapeutics, LLC | e30491ed-938e-4ef4-aa23-a2e94cbab0ed | 2025-05-29 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Bausch & Lomb Incorporated | aeab333c-3cdb-45c0-9e22-949624d69fbc | 2025-04-14 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | International Medication Systems, Limited | b72d0a82-6163-460f-965a-12f6da47370a | 2025-01-31 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Redpharm Drug Inc. | f4c35a82-5927-5bc2-e053-2a95a90aea4d | 2025-01-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Direct Rx | d9a36478-4788-4107-e053-2a95a90ad6da | 2025-01-21 | Adverse reactions | 03J5ZE7KA5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.